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Mitral valve annular calcification (MAC) may involve the mitral valve architecture and result in leaflet restriction. Although in such instances conventional mitral valve replacement (MVR) surgery remains the first-line treatment for stenosis and regurgitation, the presence of MAC may require surgical d ebridement and result in ventricular or atrioventricular groove rupture and damage to the adjacent coronary arteries. With surgical morbidity and mortality remaining high, 1 there has been interest in less invasive transcatheter therapies with balloon inflatable transcatheter aortic valves. Although these have shown some early promise, with reported technical success rates at specialist centers as great as 77%, periprocedural complications remain high. Immediate left ventricular outflow tract obstruction (LVOTO) occurs in as many as 11.2% cases, a second valve is required in 14.7% of cases, and valve embolization occurs in 4.3% of cases. Similarly, 1-year cardiovascular and all-cause mortalities remain high at 23.5% and 53.7%, respectively. 2, 3 These observations suggest that there may be scope to refine patient selection and better guide procedural deployment of these valves in the MAC position.
CASE REPORT
An 83-year-old man with coronary artery disease and severe mixed mitral and aortic valve disease was referred for double valve surgery and coronary artery bypass grafting.
At surgery, the patient underwent aortic valve replacement with a 23-mm Trifecta bioprosthesis (St Jude Medical Inc, St. Paul, Minn) and single-vessel grafting to the distal right coronary artery. Because of the degree of MAC, surgical MVR was deferred in preference for an open valvotomy.
At 12 months, the patient had a progression of symptoms and presented to our institution for consideration of transcatheter MVR with an aortic bioprosthesis within the calcification in the mitral position. Patient suitability was determined by using transthoracic echocardiography to evaluate the mitral stenosis and left ventricular function and multiphase cardiac computed tomography to characterize the MAC and its geometry ( Figure 1, A and B) . From the computed tomographic scans, additional 3-dimensional computer models of the left side of the heart were created with image-dedicated segmentation techniques (Mimics software v18.0; Materialise, Leuven, Belgium) by FEops (Ghent, Belgium). The output of this segmentation process was subsequently used to generate a finite element mesh of the complete mitral valve apparatus, including the calcified mitral valve annulus, the mitral valve leaflets, and the chordae tendineae. Varying mechanical properties were automatically assigned to different tissue regions. After this, detailed computer models of the valve FIGURE 1. A, Cardiac computed tomographic scan 3-chamber view showing the bioprosthetic aortic valve in situ and the mitral valve (MV) annular calcification (asterisk). B, Cardiac computed tomographic scan short-axis view at the level of the mitral valve annulus showing the heavy annular calcification (asterisks), its elliptical geometry, and its noncircumferential distribution. The length of the anterior leaflet of the mitral valve was 22 mm. There was mild thickening at the basal septum of 14 mm, but the remainder of the myocardium had a normal wall thickness of 10 mm. C, Computer-simulated image produced with cardiac computed tomographic segmentation and the application of finite element analysis. The model accounts for the mitral valve annular calcification (asterisks), the mitral valve leaflets, and the basal, strut, and mitral valve leaflet chordae tendineae. From the model, various sizes of transcatheter valves can be virtually deployed into the mitral valve annulus at various heights, enabling prediction of calcium deformation, paravalvular regurgitation, and left ventricular outflow tract obstruction. The image shows the virtual deployment of an Edwards SAPIEN 3 valve (Edwards Lifesciences Corporation, Irvine, Calif) in the mitral valve annulus. D, Real-time computed tomographic 3-dimensional simulation fluoroscopic fusion showing the guidewire crossing the mitral valve. The optimal implant zone is marked by the vertical orange and green lines (rings seen edge on, indicating the superior and inferior boundaries, respectively, of the intended valve position). The undeployed SAPIEN 3 valve (arrow) is seen being positioned between these points over the guidewire. The superior and inferior horizontal yellow and green rings represent the superior and inferior vena cava entry points into the right atrium. Asterisk indicates mitral annular calcification; yellow ring indicates superior vena cava boundary; green ring indicates inferior vena cava boundary; superior orange e136
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Adult: Mitral Valve: Case Reports ADULT that accurately represented mechanical device behavior (eg, braided wires and locking mechanism) were virtually implanted in the patient-specific left heart models by means of finite element simulations. All steps of the clinical implantation were respected. This included valve size selection, implantation position, and computer simulation that was based on finite element analysis to predict calcium deformation, implantation height, and LVOTO after virtual device deployment (Figure 1, C) . 4 Data analysis predicted an optimal outcome for transcatheter MVR in MAC, with positioning of the valve with no LVOTO (left ventricular outflow tract gradient before the procedure of 3.7 mm Hg vs 11.5 mm Hg after the procedure) or paravalvular regurgitation. At 6 weeks, the patient's symptoms had improved to New York Heart Association functional class II, with transthoracic echocardiography and cardiac CT showing an excellent result, consistent with the expected outcome from the preprocedural planning ( Figure 1 , E and F).
Limitations
Currently, the application of computer simulation to patients with MAC is of investigational use only. The practicality and commercial cost of this technique cannot be answered at this stage.
CONCLUSIONS
This case demonstrates the potential of bioengineering and computer simulation to facilitate better patient selection for complex mitral structural interventions. Incorporation of this technique into real-time procedural guidance may optimize device deployment to targeted zones.
